Hjem › Leiomyosarkom › Californien
Leiomyosarkom kliniske forsøg i Californien
9 studier for Leiomyosarkom søger deltagere på steder i Californien.
Byer i Californien
Officiel studietekst (engelsk)
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
- City of Hope Comprehensive Cancer Center, Duarte
- UCI Health-Chao Family Comp CC and Ambulatory Care, Irvine
- UC San Diego Moores Cancer Center, La Jolla
- og 1 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 10. sep. 2026 · NCT04031677Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
- Los Angeles General Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 4. sep. 2026 · NCT05711615STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas
- University of California, San Francisco, San Francisco
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 25. aug. 2026 · NCT06975293Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
- Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
RekruttererTidlig fase 1
Alder 18 og opefter · Alle køn · Opdateret 31. jul. 2026 · NCT07628634AOH1996 for the Treatment of Refractory Solid Tumors
- City of Hope Medical Center, Duarte
- City of Hope at Long Beach Elm, Long Beach
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 28. jul. 2026 · NCT05227326Metastatic Leiomyosarcoma Biomarker Protocol
- Sarcoma Oncology Research Center, Santa Monica
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 24. jun. 2026 · NCT05653388A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
- Precision NextGen Oncology and Research Center, Beverly Hills
- Sarcoma Oncology Center, Santa Monica
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 11. jun. 2026 · NCT06789172Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)
- Sarcoma Oncology Center, Santa Monica
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 25. feb. 2026 · NCT03016819Metronomic Trabectedin, Gemcitabine, and Dacarbazine for Soft Tissue Sarcoma
- Sant P Chawla, Santa Monica
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 24. feb. 2025 · NCT04535271Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.